Prostate-specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer

Objective To clarify the impact of prostate‐specific antigen screening on surgical outcomes of prostate cancer. Methods Patients who underwent radical prostatectomy were divided into two groups according to prostate‐specific antigen testing opportunity (group 1, prostate‐specific antigen screening; group 2, non‐prostate‐specific antigen screening). Perioperative clinical characteristics were compared using the Wilcoxon rank‐sum and χ 2 ‐tests....